Suppr超能文献

荷兰国家自发报告系统的信号:特征和监管行动。

Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actions.

机构信息

Netherlands Pharmacovigilance Centre Lareb, 's Hertogenbosch, The Netherlands.

Utrecht University, Utrecht, The Netherlands.

出版信息

Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1115-1122. doi: 10.1002/pds.5246. Epub 2021 Apr 21.

Abstract

PURPOSE

The aim of the study is to characterise safety signals based on the Dutch spontaneous reporting system (SRS) and to investigate the association between signal characteristics and Product Information (PI) update stratified by approval type: centrally authorised products (CAPs) versus nationally and decentralised authorised products (NAPs).

METHODS

This study evaluates the full cohort of signals disseminated from the Dutch SRS in the period from 2008 to 2017. Each retrieved signal was characterised on a number of aspects. The signal management process from signal generation to a potential PI update was analysed in four steps: (1) signal characterisation; (2) proposed actions by the Dutch national competent authority (NCA) for the signals; (3) presence of PI update (yes/no) and association with signal characteristics; (4) timing from the moment the signal was issued to PI update. For step 1-3 we stratified products in CAPs and NAPs.

RESULTS

Of all signals, 88.7% led to a proposed regulatory action by the NCA. Signals from the Dutch SRS for CAPs versus NAPs more often concerned biologicals, important medical events, class effects and shorter periods since marketing authorization. We detected PI updates for 26.2% of CAP signals and 61.3% of NAP signals.

CONCLUSIONS

The Dutch SRSs remains an important source of signals. There are some notable differences in the characteristics of signals for CAPs versus NAPs. Signals for NAPs more frequently led to PI updates.

摘要

目的

本研究旨在基于荷兰自发报告系统(SRS)对安全性信号进行特征描述,并调查信号特征与产品信息(PI)更新之间的关联,按批准类型分层:集中批准产品(CAPs)与国家和分散批准产品(NAPs)。

方法

本研究评估了 2008 年至 2017 年期间从荷兰 SRS 传播的完整信号队列。对每个检索到的信号进行了多个方面的特征描述。从信号生成到潜在 PI 更新的信号管理过程分为四个步骤进行分析:(1)信号特征描述;(2)荷兰国家主管当局(NCA)对信号提出的行动建议;(3)PI 更新的存在(是/否)以及与信号特征的关联;(4)从发出信号到 PI 更新的时间。在步骤 1-3 中,我们对 CAPs 和 NAPs 产品进行了分层。

结果

所有信号中,88.7%导致 NCA 提出监管行动建议。来自荷兰 SRS 的 CAP 信号与 NAP 信号更常涉及生物制品、重要医疗事件、类效应和自上市授权以来的较短时间。我们检测到 CAP 信号的 PI 更新率为 26.2%,NAP 信号的 PI 更新率为 61.3%。

结论

荷兰 SRS 仍然是信号的重要来源。CAP 与 NAP 的信号特征存在一些显著差异。NAP 的信号更频繁地导致 PI 更新。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验